# Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients

> **NCT07055503** · — · ENROLLING_BY_INVITATION · sponsor: **University Research Institute for the Study of Genetic & Malignant Disorders in Childhood** · enrollment: 30 (estimated)

## Conditions studied

- Transfusion-dependent Beta-Thalassemia
- Blood Transfusion

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07055503
- **Lead sponsor:** University Research Institute for the Study of Genetic & Malignant Disorders in Childhood
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-11-20
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-12-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07055503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07055503, "Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07055503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*